An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

NCT05560009 · clinicaltrials.gov ↗

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Soft Tissue Sarcoma
Resectable Soft Tissue Sarcoma
Soft Tissue Sarcoma

Interventions

DRUG: Fluorodopa F 18
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
RADIATION: Radiation Therapy
PROCEDURE: Surgical Procedure

Sponsor

Mayo Clinic